[HTML][HTML] Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
…, D Palova, GP Rolkova, K Tomkova, NT Csokova… - …, 2022 - thelancet.com
Background The emergence of new SARS-CoV-2 variants of concern B.1.1.7 (Alpha), B.1.351
(Beta), P.1 (Gamma) and B.1.617.2 (Delta) that harbor mutations in the viral S protein …
(Beta), P.1 (Gamma) and B.1.617.2 (Delta) that harbor mutations in the viral S protein …
[HTML][HTML] Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS
…, M Zilkova, M Cente, NT CSOKOVA… - Physiological …, 2024 - ncbi.nlm.nih.gov
Angiotensin-converting enzyme 2 (ACE2), one of the key enzymes of the renin-angiotensin
system (RAS), plays an important role in SARS-CoV-2 infection by functioning as a virus …
system (RAS), plays an important role in SARS-CoV-2 infection by functioning as a virus …
The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease.
D Palova, NT Csokova, K Markova… - General Physiology …, 2021 - search.ebscohost.com
Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
progressive memory decline, histopathological lesions such as amyloid ß plaques and …
progressive memory decline, histopathological lesions such as amyloid ß plaques and …
Second-Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of Concern
…, G Paulíkova Rolkova, K Tomkova, NT Csokova… - bioRxiv, 2021 - biorxiv.org
Recently emerged SARS-CoV-2 variants show resistance to some antibodies that were
authorized for emergency use. We employed hybridoma technology combined with authentic …
authorized for emergency use. We employed hybridoma technology combined with authentic …
Second Generation Antibodies Neutralize Emerging SARS-CoV-2 Variants of Concern (preprint)
…, D Palova, GP Rolkova, K Tomkova, NT Csokova… - 2021 - pesquisa.bvsalud.org
Recently emerged SARS-CoV-2 variants show resistance to some antibodies that were
authorized for emergency use. We employed hybridoma technology combined with authentic …
authorized for emergency use. We employed hybridoma technology combined with authentic …
[CITATION][C] Monoclonal antibodies neutralizing circulating SARS-CoV-2 variants of concern
…, K Tomkova, NT Csokova… - EUROPEAN …, 2023 - … ST, HOBOKEN 07030-5774, NJ USA